Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares UltraShort Silver

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily FTSE China Bull 3X ETF

ProShares Ultra Bloomberg Natural Gas

T-REX 2X Inverse Tesla Daily Target ETF

MicroSectors Gold Miners 3X Leveraged ETN

Volatility Shares Trust 2x Ether ETF

ProShares Ultra Silver

United States Natural Gas

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

ARK Genomic Revolution Multi-Sector ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

Rigetti Computing Inc. Common Stock

Super Micro Computer Inc. Common Stock

Oklo Inc.

EchoStar  Corporation Common Stock

Spire Global Inc. Class A Common Stock

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Oriental Rise Holdings Limited Ordinary Shares

Classover Holdings Inc. Class B Common Stock

Hyperscale Data Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

JELD-WEN Holding Inc. Common Stock

Click here to get full coverage on Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight - Nasdaq

Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight  Nasdaq

Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight - Nasdaq

Click here to get full coverage on A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts - Benzinga

A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts  Benzinga

A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts - Benzinga

Click here to get full coverage on Reaction: Taskmaster, "An Invisible Jump Rope" | Season 19, Episode 2 - Episodic Medium

Reaction: Taskmaster, "An Invisible Jump Rope" | Season 19, Episode 2  Episodic Medium

Reaction: Taskmaster, "An Invisible Jump Rope" | Season 19, Episode 2 - Episodic Medium

Click here to get full coverage on Eton Pharmaceuticals: Buy Rating Backed by Successful Relaunches and Promising Growth Prospects - TipRanks

Eton Pharmaceuticals: Buy Rating Backed by Successful Relaunches and Promising Growth Prospects  TipRanks

Eton Pharmaceuticals: Buy Rating Backed by Successful Relaunches and Promising Growth Prospects - TipRanks

Click here to get full coverage on Eton Pharmaceuticals Reports First Quarter 2025 Financial Results - Yahoo Finance

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results  Yahoo Finance

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results - Yahoo Finance

Click here to get full coverage on Eton Advisors Enhances Rebalancing and Trading with intelliflo redblack - Business Wire

Eton Advisors Enhances Rebalancing and Trading with intelliflo redblack  Business Wire

Eton Advisors Enhances Rebalancing and Trading with intelliflo redblack - Business Wire

Click here to get full coverage on Eton Pharmaceuticals Sees Composite Rating Move Up To 96 - Investor's Business Daily

Eton Pharmaceuticals Sees Composite Rating Move Up To 96  Investor's Business Daily

Eton Pharmaceuticals Sees Composite Rating Move Up To 96 - Investor's Business Daily

Click here to get full coverage on Eton Reports Breakthrough Quarter: 76% Revenue Growth and 17 Straight Quarters of Sales Gains - Stock Titan

Eton Reports Breakthrough Quarter: 76% Revenue Growth and 17 Straight Quarters of Sales Gains  Stock Titan

Eton Reports Breakthrough Quarter: 76% Revenue Growth and 17 Straight Quarters of Sales Gains - Stock Titan

Click here to get full coverage on The heartbreaking truth behind Prince Harry’s school experience revealed - hellomagazine.com

The heartbreaking truth behind Prince Harry’s school experience revealed  hellomagazine.com

The heartbreaking truth behind Prince Harry’s school experience revealed - hellomagazine.com

Click here to get full coverage on Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard - WKYC

Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard  WKYC

Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard - WKYC

Click here to get full coverage on Eton Chagrin Boulevard announces new tenants - Crain's Cleveland Business

Eton Chagrin Boulevard announces new tenants  Crain's Cleveland Business

Eton Chagrin Boulevard announces new tenants - Crain's Cleveland Business

Click here to get full coverage on Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025  GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewswire

Click here to get full coverage on Bryan Henning of Eton Solutions: Building Stronger Foundations for AI in Family Offices and Wealth Management - Hubbis

Bryan Henning of Eton Solutions: Building Stronger Foundations for AI in Family Offices and Wealth Management  Hubbis

Bryan Henning of Eton Solutions: Building Stronger Foundations for AI in Family Offices and Wealth Management - Hubbis

Click here to get full coverage on Earnings Flash (ETON) Eton Pharmaceuticals Reports Q1 Revenue $17.3M, vs. FactSet Est of $15.1M - marketscreener.com

Earnings Flash (ETON) Eton Pharmaceuticals Reports Q1 Revenue $17.3M, vs. FactSet Est of $15.1M  marketscreener.com

Earnings Flash (ETON) Eton Pharmaceuticals Reports Q1 Revenue $17.3M, vs. FactSet Est of $15.1M - marketscreener.com

Click here to get full coverage on A Look Ahead: Eton Pharmaceuticals's Earnings Forecast - Nasdaq

A Look Ahead: Eton Pharmaceuticals's Earnings Forecast  Nasdaq

A Look Ahead: Eton Pharmaceuticals's Earnings Forecast - Nasdaq

Click here to get full coverage on Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewswire

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)  GlobeNewswire

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results  GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®  GlobeNewswire

Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewswire

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules  GlobeNewswire

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewswire

Click here to get full coverage on Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - GlobeNewswire

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®  GlobeNewswire

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - GlobeNewswire

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600  GlobeNewswire

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin - World Pharmaceutical Frontiers

Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin  World Pharmaceutical Frontiers

Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin - World Pharmaceutical Frontiers

Click here to get full coverage on Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400  GlobeNewswire

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - GlobeNewswire

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600  GlobeNewswire

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release  Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on 'I hope it's huge': Eton Square owners revitalizing iconic shopping center - KJRH

'I hope it's huge': Eton Square owners revitalizing iconic shopping center  KJRH

'I hope it's huge': Eton Square owners revitalizing iconic shopping center - KJRH

Click here to get full coverage on Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - GlobeNewswire

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)  GlobeNewswire

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq

Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025  Nasdaq

Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq

Click here to get full coverage on Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 33% - simplywall.st

Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 33%  simplywall.st

Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 33% - simplywall.st

Click here to get full coverage on Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million - Business Wire

Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million  Business Wire

Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million - Business Wire

Click here to get full coverage on Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up - Tatler

Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up  Tatler

Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up - Tatler

Click here to get full coverage on Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India - Business Wire

Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India  Business Wire

Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India - Business Wire

Click here to get full coverage on Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags  Yahoo Finance

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Click here to get full coverage on Eton reloaded: Lucio Tan reboots real estate empire with P3.5B lifeline - Bilyonaryo Business News

Eton reloaded: Lucio Tan reboots real estate empire with P3.5B lifeline  Bilyonaryo Business News

Eton reloaded: Lucio Tan reboots real estate empire with P3.5B lifeline - Bilyonaryo Business News

Click here to get full coverage on Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms - Business Wire

Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms  Business Wire

Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms - Business Wire

Click here to get full coverage on My Eton tormentor has been jailed - The Spectator

My Eton tormentor has been jailed  The Spectator

My Eton tormentor has been jailed - The Spectator

Click here to get full coverage on Eton secures US patent for diabetes insipidus treatment - Pharmaceutical Technology

Eton secures US patent for diabetes insipidus treatment  Pharmaceutical Technology

Eton secures US patent for diabetes insipidus treatment - Pharmaceutical Technology

Click here to get full coverage on Major Pharma Deal: Eton's Smart Move Unlocks Global Market for Rare Disease Treatment - Stock Titan

Major Pharma Deal: Eton's Smart Move Unlocks Global Market for Rare Disease Treatment  Stock Titan

Major Pharma Deal: Eton's Smart Move Unlocks Global Market for Rare Disease Treatment - Stock Titan

Click here to get full coverage on Priest who gave sermon to Prince Harry when he was at Eton calls on him to stop 'playing the victim' - Scottish Daily Express

Priest who gave sermon to Prince Harry when he was at Eton calls on him to stop 'playing the victim'  Scottish Daily Express

Priest who gave sermon to Prince Harry when he was at Eton calls on him to stop 'playing the victim' - Scottish Daily Express

Click here to get full coverage on Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results  GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)  GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewswire

Click here to get full coverage on One of Britain’s Most Dominant Sportsmen Has Stiff Joints and Works in Finance - WSJ

One of Britain’s Most Dominant Sportsmen Has Stiff Joints and Works in Finance  WSJ

One of Britain’s Most Dominant Sportsmen Has Stiff Joints and Works in Finance - WSJ

Click here to get full coverage on Eton Pharmaceuticals submits NDA for its diabetes insipidus treatment (ETON:NASDAQ) - Seeking Alpha

Eton Pharmaceuticals submits NDA for its diabetes insipidus treatment (ETON:NASDAQ)  Seeking Alpha

Eton Pharmaceuticals submits NDA for its diabetes insipidus treatment (ETON:NASDAQ) - Seeking Alpha

Click here to get full coverage on LT Group bets big on Eton - Inquirer.net

LT Group bets big on Eton  Inquirer.net

LT Group bets big on Eton - Inquirer.net

Click here to get full coverage on Prince George on Cusp of Major Life Decision - Newsweek

Prince George on Cusp of Major Life Decision  Newsweek

Prince George on Cusp of Major Life Decision - Newsweek

Click here to get full coverage on Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain - Yahoo Finance

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain  Yahoo Finance

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum - Yahoo Finance

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum  Yahoo Finance

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum - Yahoo Finance

Click here to get full coverage on Eton acquires US rights to neonatal diabetes treatment from AMMTeK - Pharmaceutical Technology

Eton acquires US rights to neonatal diabetes treatment from AMMTeK  Pharmaceutical Technology

Eton acquires US rights to neonatal diabetes treatment from AMMTeK - Pharmaceutical Technology

Click here to get full coverage on Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services - Yahoo Finance

Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services  Yahoo Finance

Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services - Yahoo Finance

Click here to get full coverage on Digital Digest: The Latest Tech News – Eton Solutions, India - Family Wealth Report

Digital Digest: The Latest Tech News – Eton Solutions, India  Family Wealth Report

Digital Digest: The Latest Tech News – Eton Solutions, India - Family Wealth Report

Click here to get full coverage on Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - Yahoo Finance

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025  Yahoo Finance

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)  GlobeNewswire

ETON

Price Chart

Key Statistics

Technicals

About ETON

Latest News

Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight - Nasdaq

A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts - Benzinga

Reaction: Taskmaster, "An Invisible Jump Rope" | Season 19, Episode 2 - Episodic Medium

Advanced Charts

Top Gainers

Top Losers